An Open Label Study of the Safety, Efficacy and Pharmaco

Project: Research project

Description

An Open Label Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate (GPB; RAVICTI) in Pediatric Subjects under Two Years of Age with Urea Cycle Disorders (UCDs)
StatusFinished
Effective start/end date8/25/14 → 12/31/18

Funding

  • Hyperion Therapeutics
View all
View less

Fingerprint

Inborn Urea Cycle Disorder
Pharmacokinetics
Pediatrics
Safety
glycerol phenylbutyrate